BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34817875)

  • 1. Definitive weekly hypofractionated radiotherapy in cutaneous squamous cell carcinoma: response rates and outcomes in elderly patients unfit for surgery.
    De Felice F; Musio D; De Falco D; Grapulin L; Magnante AL; Caiazzo R; Bulzonetti N; Tombolini V
    Int J Dermatol; 2022 Aug; 61(8):911-915. PubMed ID: 34817875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgery-ineligible elderly patients with cutaneous squamous cell carcinoma of the head and neck region gain clinical benefit from definitive weekly hypofractionated radiotherapy.
    De Felice F; Serpone M; Cattaneo CG; Di Giammarco F; Fallico A; Delle Donne A; Lanzilao M; Vitti E; Marampon F; Musio D; Tombolini V; Minniti G
    Head Neck; 2023 Sep; 45(9):2363-2368. PubMed ID: 37439379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Definitive weekly hypofractionated radiotherapy in surgery-ineligible older adults with cutaneous squamous cell carcinoma of the head and neck region.
    De Felice F; Serpone M; Cattaneo CG; Di Giammarco F; Fallico A; Delle Donne A; Lanzilao M; Vitti E; Marampon F; Musio D; Tombolini V; Minniti G
    J Geriatr Oncol; 2024 Jan; 15(1):101596. PubMed ID: 37517887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weekly hypofractionated radiation therapy in elderly non-resectable cutaneous squamous cell carcinoma of the head and neck region.
    De Felice F; Musio D; Tombolini V
    Radiol Med; 2021 Apr; 126(4):620-622. PubMed ID: 33058025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of primary and adjuvant radiotherapy for cutaneous squamous cell carcinomas of the head-and-neck region in the elderly.
    Haehl E; Rühle A; Klink R; Kalckreuth T; Sprave T; Gkika E; Zamboglou C; Meiß F; Grosu AL; Nicolay NH
    Radiat Oncol; 2021 Jun; 16(1):105. PubMed ID: 34118984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artificial neural networks allow response prediction in squamous cell carcinoma of the scalp treated with radiotherapy.
    Damiani G; Grossi E; Berti E; Conic RRZ; Radhakrishna U; Pacifico A; Bragazzi NL; Piccinno R; Linder D
    J Eur Acad Dermatol Venereol; 2020 Jun; 34(6):1369-1373. PubMed ID: 31968143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypofractionated radiotherapy denoted as the "Christie scheme": an effective means of palliating patients with head and neck cancers not suitable for curative treatment.
    Al-mamgani A; Tans L; Van rooij PH; Noever I; Baatenburg de jong RJ; Levendag PC
    Acta Oncol; 2009; 48(4):562-70. PubMed ID: 19373698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Split-course hypofractionated radiotherapy for aged and frail patients with head and neck cancers. A retrospective study of 75 cases.
    Benhmida S; Sun R; Gherga E; Hammoud Y; Rouvier J; Mauvais O; Bockel S; Louvrier A; Lebbad A; Bontemps P; Ortholan C; Bourhis J; Lestrade L; Sun XS
    Cancer Radiother; 2020 Dec; 24(8):812-819. PubMed ID: 33144061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mono- and Bi-weekly Hypofractionated Radiation Therapy for the Treatment of Epithelial Skin Cancer in Very Elderly Patients.
    Valeriani M; Nicosia L; Agolli L; Reverberi C; Galvagno E; DE Sanctis V; Minniti G; Carlesimo M; Osti MF
    Anticancer Res; 2017 Feb; 37(2):825-830. PubMed ID: 28179337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypofractionated radiotherapy alone with 2.4 Gy per fraction for head and neck cancer during the COVID-19 pandemic: The Princess Margaret experience and proposal.
    Huang SH; O'Sullivan B; Su J; Ringash J; Bratman SV; Kim J; Hosni A; Bayley A; Cho J; Giuliani M; Hope A; Spreafico A; Hansen AR; Siu LL; Gilbert R; Irish JC; Goldstein D; de Almeida J; Tong L; Xu W; Waldron J
    Cancer; 2020 Aug; 126(15):3426-3437. PubMed ID: 32478895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elderly patients affected by head and neck squamous cell carcinoma unfit for standard curative treatment: Is de-intensified, hypofractionated radiotherapy a feasible strategy?
    Bonomo P; Desideri I; Loi M; Lo Russo M; Olmetto E; Maragna V; Francolini G; Delli Paoli C; Grassi R; Pezzulla D; Greto D; Meattini I; Livi L
    Oral Oncol; 2017 Nov; 74():142-147. PubMed ID: 29103743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moderately Hypofractionated Radiotherapy Without Chemotherapy in Elderly or Frail Patients With Head and Neck Cancer.
    Fryen A; Brandes I; Wichmann J; Christiansen H; Tavassol F; Durisin M; Merten R
    In Vivo; 2022; 36(3):1259-1266. PubMed ID: 35478110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical management of recurrent cutaneous squamous cell carcinoma of the head and neck after definitive surgery and radiotherapy.
    Toppi J; Tham YS; Webb A; Henderson MA; Rischin D; Magarey MJR
    ANZ J Surg; 2020 Jul; 90(7-8):1391-1395. PubMed ID: 32627359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility of concomitant cisplatin with hypofractionated radiotherapy for locally advanced head and neck squamous cell carcinoma.
    Jacinto AA; Batalha Filho ES; Viana LS; De Marchi P; Capuzzo RC; Gama RR; Boldrini Junior D; Santos CR; Pinto GDJ; Dias JM; Canton HP; Carvalho R; Radicchi LA; Bentzen S; Zubizarreta E; Carvalho AL
    BMC Cancer; 2018 Oct; 18(1):1026. PubMed ID: 30352576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cetuximab-radiotherapy combination in the management of locally advanced cutaneous squamous cell carcinoma.
    Joseph K; Alkaabi K; Warkentin H; Ghosh S; Jha N; Smylie M; Walker J
    J Med Imaging Radiat Oncol; 2019 Apr; 63(2):257-263. PubMed ID: 30549229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclical hypofractionated radiotherapy also known as "QUAD Shot" alone using intensity-modulated radiotherapy for squamous cell carcinoma of the parotid gland in an 85-year-old patient with multiple comorbidities.
    Kil WJ; Camphausen K
    Head Neck; 2017 Apr; 39(4):E55-E60. PubMed ID: 28170130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An evolving paradigm for the workup and management of high-risk cutaneous squamous cell carcinoma.
    O'Bryan K; Sherman W; Niedt GW; Taback B; Manolidis S; Wang A; Ratner D
    J Am Acad Dermatol; 2013 Oct; 69(4):595-602.e1. PubMed ID: 23871719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. End stage palliative care of head and neck cancer: a case study.
    Shishodia NP; Divakar DD; Al Kheraif AA; Ramakrishnaiah R; Pathan AA; Parine NR; Chandroth SV; Purushothaman B
    Asian Pac J Cancer Prev; 2015; 16(3):1255-8. PubMed ID: 25735365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weekly hypofractionated radiotherapy in older adult patients with cutaneous squamous cell carcinoma.
    De Felice F; Musio D; De Falco D; Grapulin L; Magnante AL; Caiazzo R; Bulzonetti N; Tombolini V
    J Geriatr Oncol; 2022 Mar; 13(2):256-257. PubMed ID: 34538637
    [No Abstract]   [Full Text] [Related]  

  • 20. [SIB-IMRT radiotherapy given concomitantly with cisplatin for locally advanced squamous cell head and neck cancer (SCHNC). Evaluation of the early results and toxicity].
    Kiprian D; Jarząbski A; Pawłowska B; Michalski W; Kawecki A
    Otolaryngol Pol; 2011 Sep; 65(5 Suppl):117-25. PubMed ID: 22000261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.